Dual-Activity Nanoparticles for Sequential Radiation Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current radiation therapies for treating pathological body parts, such as tumors, often face challenges in achieving effective treatment while minimizing damage to healthy cells and reducing side effects, due to limitations in radiation delivery and distribution.

Innovation Solution

The use of nanoparticles with two centers of activity for free radical production, one in the core and one in the coating, which are preferentially irradiated to amplify radiation effects and spatially or temporally sequenced to enhance treatment efficacy and reduce side effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If standard radiation therapy is applied to treat pathological cells, then radiation delivery is simplified, but treatment efficacy is insufficient and damage to healthy cells occurs

Engineering Contradiction:
Improvetreatment efficacyVSAvoiddamage to healthy cells
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The nanoparticle is segmented into distinct functional zones: a core containing first free radical production centers and a coating containing second free radical production centers. This segmentation allows independent optimization of each zone's function and enables controlled sequential activation, improving treatment efficacy while protecting healthy tissues through spatial and temporal separation of radiation effects

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the nanoparticle are assigned different functional qualities: the core contains photo-sensitizers activated by first radiation, while the coating contains radio-sensitizers activated by second radiation. This local differentiation of functional properties enables targeted free radical production at specific locations and times, maximizing pathological cell destruction while minimizing damage to surrounding healthy cells

Inventive Principle:
Principle #3Local quality

2Quantity of substance

If continuous intense radiation is applied to maximize free radical production, then treatment efficacy increases, but side effects increase

Engineering Contradiction:
Improvefree radical productionVSAvoidside effects
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The treatment employs periodic alternating radiation sequences where the nanoparticle is exposed to first radiation (activating core photo-sensitizers), then to second radiation (activating coating radio-sensitizers), with intermittent periods in between. This periodic activation pattern maintains high free radical production over time while allowing tissue recovery during intervals, thereby reducing cumulative side effects

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The dual-center nanoparticle design ensures continuous free radical production throughout the treatment cycle by sequentially activating different centers. While the core centers are active during first radiation exposure, the coating centers are activated during second radiation exposure, ensuring that useful therapeutic action continues without interruption despite alternating radiation types and intermittent timing

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach increases the production of free radicals and amplifies radiation effects, leading to enhanced destruction of pathological cells while preserving healthy cells, thereby improving treatment outcomes and reducing side effects.

Implementation Method 1

comprising a first center of activity or free radical production C1FRP in its core, and a second center of activity or free radical production C2FRP in its coating

Methodology Applied
Scientific EffectFree radical production: Ionisation

Implementation Method 2

amplifying the radiation, amplifying the effect of the radiation

Methodology Applied
Scientific EffectRadiation amplification: Radiation

Implementation Method 3

increasing the destruction of the body part, preferentially pathological or tumor cells or a tumor or cancer

Methodology Applied
Scientific EffectRadiation-induced cell destruction: Ablation

Data Source

PatentEP4371575A1Combining spatial and temporal sequences of irradiation using a specific nano-system for an improved treatment of diseases such as cancer
Publication Date: 2024.05.22 ALPHAONCO
  • EP4371575A1 patent drawing
  • EP4371575A1 patent drawing

AI summary

The invention relates to nanoparticle for use in a method, for increasing the production of free radicals or amplifying radiation during a sonodynamic, photodynamic or radiation therapy or exposure of a body part to a radiation, comprising the steps of: 1) Preferentially introducing or reintroducing in a body part to be treated at least one nanoparticle comprising: - Preferentially a first center of a first center activity, CA1, such as a first center of free radical production or radiation amplification, C1FRP, comprised in its core, and - Preferentially a second center of activity, CA2, such as a second center of free radical production or radiation amplification, C2FRP, comprised in its coating, 2) Preferentially applying an external radiation on the body part comprising the nanoparticle(s) during a time t1; 3) Preferentially not applying the external radiation on the body part comprising the nanoparticle(s) during a time t2 or applying a radiation of lower intensity, energy, power or power density during the time t2 than during the time t1; 4) Preferentially re-applying the external radiation on the body part comprising the nanoparticle(s) during a time t3 or applying an external radiation of larger intensity, energy, power or power density during t3 than during t2;